Pharmacists suggested how to monitor and alter the dose of enoxaparin for trauma patients in the Surgical Intensive Care Unit (SICU). Medical practitioners frequently approved pharmacist suggestions, leading to trauma patients often reaching the desired AFXa-TR level after pharmacist-recommended dosage adjustments. Additional study is needed to determine the most effective enoxaparin dosage for preventing VTE in trauma patients. Enoxaparin anti-Xa levels are commonly measured inaccurately, leading to dosage modifications being made without proper support from these levels. This might pose a risk to patient safety.